SEC Form 4Coverage since Jun 9, 2026
$BCDA insider trading
Over the last 12 months, BioCardia insiders reported 8 buys totaling $130K and no sales across SEC Form 4 filings.
- Bought · 12m
- $130K 8 events
- Sold · 12m
- — 0 events
- Events · 12m
- 8 Form 4 filings, grouped
- Insiders · 12m
- 2 distinct reporters
- 10b5-1 share
- 0% pre-arranged plans
Side
Price · $BCDA · 12Mvia TradingView
Top insiders · 12m
Altman PeterPresident and CEO7× · $27K
STERTZER SIMON H—1× · $104K
All insider trades
8 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 29, 2026 | Altman PeterPresident and CEO · O·D | ▲ Buy | 5,000 | $0.78 | $4K | +1.4% | — |
| Jul 17, 2026 | Altman PeterPresident and CEO · O·D | ▲ Buy | 500 | $0.83 | $415 | +0.1% | — |
| Jul 15, 2026 | Altman PeterPresident and CEO · O·D | ▲ Buy | 4,300 | $0.87 | $4K | +1.2% | 2 tranches |
| Jul 10, 2026 | Altman PeterPresident and CEO · O·D | ▲ Buy | 7,500 | $0.96 | $7K | +2.1% | 3 tranches |
| Jul 8, 2026 | Altman PeterPresident and CEO · O·D | ▲ Buy | 5,400 | $0.96 | $5K | +1.5% | — |
| Jun 23, 2026 | STERTZER SIMON HD | ▲ Buy | 109,200 | $0.95 | $104K | +191.1% | 2 tranches |
| Jun 18, 2026 | Altman PeterPresident and CEO · O·D | ▲ Buy | 2,300 | $0.89 | $2K | +0.8% | 2 tranches |
| Jun 9, 2026 | Altman PeterPresident and CEO · O·D | ▲ Buy | 5,000 | $0.85 | $4K | +1.7% | — |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $BCDA feed.